Metformin in Gestational Diabetes: the Offspring Follow-up (MiG TOFU): Body Composition and Metabolic Outcomes at 7-9 Years of Age

Overview

Journal BMJ Open Diabetes Res Care

Specialty Endocrinology

Date 2018 Apr 24

PMID 29682291

Citations 96

Authors

Janet A Rowan

Elaine C Rush

Lindsay D Plank

Jun Lu

Victor Obolonkin

Suzette Coat

William M Hague

Affiliations

Soon will be listed here.

Abstract

Objective: To compare body composition and metabolic outcomes at 7-9 years in offspring of women with gestational diabetes (GDM) randomized to metformin (±insulin) or insulin treatment during pregnancy.

Research Design And Methods: Children were assessed at 7 years in Adelaide (n=109/181) and 9 years in Auckland (n=99/396) by anthropometry, bioimpedance analysis (BIA), dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI) (n=92/99) and fasting bloods (n=82/99).

Results: In the Adelaide subgroup, mothers were similar at enrollment. Women randomized to metformin versus insulin had higher treatment glycemia (p=0.002) and more infants with birth weight >90th percentile (20.7% vs 5.9%; p=0.029). At 7 years, there were no differences in offspring measures. In Auckland, at enrollment, women randomized to metformin had a higher body mass index (BMI) (p=0.08) but gained less weight during treatment (p=0.07). Offspring birth measures were similar. At 9 years, metformin offspring were larger by measures of weight, arm and waist circumferences, waist:height (p<0.05); BMI, triceps skinfold (p=0.05); DXA fat mass and lean mass (p=0.07); MRI abdominal fat volume (p=0.051). Body fat percent was similar between treatment groups by DXA and BIA. Abdominal fat percentages (visceral adipose tissue, subcutaneous adipose tissue and liver) were similar by MRI. Fasting glucose, triglyceride, insulin, insulin resistance, glycosylated hemoglobin (HbA1c), cholesterol, liver transaminases, leptin and adiponectin were similar.

Conclusions: Metformin or insulin for GDM was associated with similar offspring total and abdominal body fat percent and metabolic measures at 7-9 years. Metformin-exposed children were larger at 9 years. Metformin may interact with fetal environmental factors to influence offspring outcomes.

Citing Articles

Maternal and Neonatal Efficacy and Safety Outcomes of Myo-Inositol in Women With or at High Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Ali Y, Sharara M, Mahrous M, Rezk A, Abuali A, Seoudy M Diabetes Spectr. 2025; 38(1):82-92.

PMID: 39959527 PMC: 11825409. DOI: 10.2337/ds23-0065.

Metformin versus insulin in glycemic control in pregnancy (MevIP): a randomized clinical trial protocol.

Amaral-Moreira C, Paulino D, Pereira B, Rehder P, Surita F Trials. 2025; 26(1):45.

PMID: 39923109 PMC: 11807315. DOI: 10.1186/s13063-025-08752-7.

Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes.

Brand K, Gottwald-Hostalek U, Andag-Silva A Womens Health (Lond). 2025; 21:17455057241311759.

PMID: 39899277 PMC: 11792029. DOI: 10.1177/17455057241311759.

Pacific Islands Families Study: Serum Uric Acid in Pacific Youth and the Associations with Free-Sugar Intake and Appendicular Skeletal Muscle Mass.

Jalili-Moghaddam S, Mearns G, Plank L, Tautolo E, Rush E Nutrients. 2025; 17(1.

PMID: 39796487 PMC: 11722811. DOI: 10.3390/nu17010054.

Intrauterine metformin exposure and adiposity outcomes in children: a systematic review and meta-analysis.

Fu J, Tabbara N, Tomlinson G, Murphy K, Hamilton J, Feig D BMJ Open. 2025; 15(1):e088653.

PMID: 39779258 PMC: 11749820. DOI: 10.1136/bmjopen-2024-088653.

References

Boney C, Verma A, Tucker R, Vohr B . Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005; 115(3):e290-6. DOI: 10.1542/peds.2004-1808. View

Tong J, Yan X, Zhao J, Zhu M, Nathanielsz P, Du M . Metformin mitigates the impaired development of skeletal muscle in the offspring of obese mice. Nutr Diabetes. 2013; 1:e7. PMC: 3302133. DOI: 10.1038/nutd.2011.3. View

Battin M, Obolonkin V, Rush E, Hague W, Coat S, Rowan J . Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial. BMC Pediatr. 2015; 15:54. PMC: 4429316. DOI: 10.1186/s12887-015-0372-1. View

Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

Rowan J, Gao W, Hague W, McIntyre H . Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care. 2009; 33(1):9-16. PMC: 2797992. DOI: 10.2337/dc09-1407. View

Wouldes T, Battin M, Coat S, Rush E, Hague W, Rowan J . Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal Neonatal Ed. 2016; 101(6):F488-F493. DOI: 10.1136/archdischild-2015-309602. View

Carlsen S, Martinussen M, Vanky E . Metformin's effect on first-year weight gain: a follow-up study. Pediatrics. 2012; 130(5):e1222-6. DOI: 10.1542/peds.2012-0346. View

Landon M, Spong C, Thom E, Carpenter M, Ramin S, Casey B . A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361(14):1339-48. PMC: 2804874. DOI: 10.1056/NEJMoa0902430. View

Glueck C, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P . Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod. 2004; 19(6):1323-30. DOI: 10.1093/humrep/deh263. View

10.

Schaefer-Graf U, Pawliczak J, Passow D, Hartmann R, Rossi R, Buhrer C . Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care. 2005; 28(7):1745-50. DOI: 10.2337/diacare.28.7.1745. View

11.

Wallace T, Levy J, Matthews D . Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6):1487-95. DOI: 10.2337/diacare.27.6.1487. View

12.

Rena G, Pearson E, Sakamoto K . Molecular mechanism of action of metformin: old or new insights?. Diabetologia. 2013; 56(9):1898-906. PMC: 3737434. DOI: 10.1007/s00125-013-2991-0. View

13.

Zhao L, Sheng X, Zhou S, Yang T, Ma L, Zhou Y . Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol. 2015; 80(5):1224-34. PMC: 4631195. DOI: 10.1111/bcp.12672. View

14.

Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L . Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med. 2016; 34(1):27-36. DOI: 10.1111/dme.13150. View

15.

Salomaki H, Vahatalo L, Laurila K, Jappinen N, Penttinen A, Ailanen L . Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS One. 2013; 8(2):e56594. PMC: 3574083. DOI: 10.1371/journal.pone.0056594. View

16.

Rush E, Puniani K, Valencia M, Davies P, Plank L . Estimation of body fatness from body mass index and bioelectrical impedance: comparison of New Zealand European, Maori and Pacific Island children. Eur J Clin Nutr. 2003; 57(11):1394-401. DOI: 10.1038/sj.ejcn.1601701. View

17.

Li G, Zhao S, Cui S, Li L, Xu Y, Li Y . Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. Arch Gynecol Obstet. 2014; 292(1):111-20. DOI: 10.1007/s00404-014-3566-0. View

18.

Franks P, Looker H, Kobes S, Touger L, Tataranni P, Hanson R . Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes. 2006; 55(2):460-5. DOI: 10.2337/diabetes.55.02.06.db05-0823. View

19.

Salomaki-Myftari H, Vahatalo L, Ailanen L, Pietila S, Laiho A, Hanninen A . Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure. PLoS One. 2016; 11(9):e0163805. PMC: 5040270. DOI: 10.1371/journal.pone.0163805. View

20.

Ro T, Ludvigsen H, Carlsen S, Vanky E . Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest. 2012; 72(7):570-5. DOI: 10.3109/00365513.2012.712319. View